Immuron Ltd Files 6-K with SEC

Ticker: IMRN · Form: 6-K · Filed: Sep 16, 2025 · CIK: 1660046

Immuron LTD 6-K Filing Summary
FieldDetail
CompanyImmuron LTD (IMRN)
Form Type6-K
Filed DateSep 16, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-K, disclosure

Related Tickers: IMRN

TL;DR

IMRN filed a 6-K on 9/16/25, check for updates.

AI Summary

Immuron Limited filed a Form 6-K on September 16, 2025, reporting on announcements made during September 2025. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. No specific financial figures or operational details were provided in the excerpt.

Why It Matters

This filing serves as an update for investors regarding company announcements, maintaining transparency and compliance with SEC regulations for foreign private issuers.

Risk Assessment

Risk Level: low — This filing is a routine disclosure and does not contain new material financial or operational information that would immediately impact risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, have filed or are required to file with a stock exchange, or have distributed or are required to distribute to their security holders.

What is Immuron Limited's SEC file number?

Immuron Limited's SEC file number is 001-38104.

What is Immuron Limited's primary business classification?

Immuron Limited is classified under Pharmaceutical Preparations [2834].

What is Immuron Limited's fiscal year end?

Immuron Limited's fiscal year ends on June 30 (0630).

Does Immuron Limited file annual reports under Form 20-F?

Yes, Immuron Limited indicates it files annual reports under cover of Form 20-F.

Filing Stats: 312 words · 1 min read · ~1 pages · Grade level 18.6 · Accepted 2025-09-16 06:53:18

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on September 16, 2025 titled: - CEO's presentation to Coffee Microcaps Conference A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 CEO's presentation to Coffee Microcaps Conference 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: September 16, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing